Intensity Therapeutics (INTS) Director Emer Leahy Receives 5,500-Share Award

What Happened

• Emer Leahy, a director of Intensity Therapeutics, was granted 5,500 derivative shares (reported as a grant/award) on July 16, 2026. The shares were reported at an acquisition price of $0.00 (total reported value $0). The award is recorded as a derivative instrument rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-16; Filing date: 2026-07-20 (filed 4 days after the transaction).
• Security: 5,500 shares (derivative grant) acquired at $0.00; reported total value $0.
• Vesting: Per the filing footnote, the option/award vests in four equal annual installments beginning July 16, 2026 (fully vested by July 16, 2029).
• Shares owned after transaction: not disclosed in the provided excerpt.
• Timeliness: Filing was submitted four days after the transaction (typical Form 4 deadline is 2 business days), which may be a late filing.

Context

• This was a compensation-style grant to a director (an "A" code award/derivative), common for board service. It does not reflect an immediate sale or cash proceeds and should not be read as an immediate market trade. Grants tied to service and multi-year vesting are routine director compensation and do not by themselves signal insider buying or selling intentions.